Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  dinaciclib
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Veliparib and Dinaciclib in Treating Patients with Advanced Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-144, NCI-2011-03458, CDR0000710900, DFCI-11-144, 8484, NCT01434316
Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC1113, NCI-2012-01737, CDR0000741989, NCI 9157, 9157, NCT01711528
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients with Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9231, NCI-2013-00153, J1269, NA_00075037, NCT01783171
Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155)
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 3475-155, NCI-2016-00730, MK-3475-155, NCT02684617
Start Over